|
US20030087813A1
(en)
*
|
2001-10-12 |
2003-05-08 |
Or Yat Sun |
Cyclosporin analogs for the treatment of lung diseases
|
|
HUP0402318A3
(en)
*
|
2001-12-14 |
2012-09-28 |
Jagotec Ag |
Pharmaceutical composition comprising cyclosporin and use thereof
|
|
US20040110666A1
(en)
*
|
2002-12-04 |
2004-06-10 |
Or Yat Sun |
Cyclosporins for the treatment of immune disorders
|
|
US7012065B2
(en)
*
|
2003-02-07 |
2006-03-14 |
Enanta Pharmaceuticals, Inc. |
Cyclosporins for the treatment of immune disorders
|
|
US20040261140A1
(en)
*
|
2003-03-07 |
2004-12-23 |
Benson John D. |
Transgenic mice expressing human formyl peptide receptor
|
|
EP1603512A2
(en)
*
|
2003-03-17 |
2005-12-14 |
Albany Molecular Research, Inc. |
Novel cyclosporins
|
|
US20050059583A1
(en)
|
2003-09-15 |
2005-03-17 |
Allergan, Inc. |
Methods of providing therapeutic effects using cyclosporin components
|
|
US7226906B2
(en)
*
|
2004-08-16 |
2007-06-05 |
Array Biopharma, Inc. |
Cyclosporin analogs for the treatment of immunoregulatory disorders and respiratory diseases
|
|
US20060035821A1
(en)
*
|
2004-08-16 |
2006-02-16 |
Hunt Kevin W |
Cyclosporin analogs for the treatment of immunoregulatory disorders and respiratory diseases
|
|
US7378391B2
(en)
*
|
2004-09-29 |
2008-05-27 |
Amr Technology, Inc. |
Cyclosporin alkyne analogues and their pharmaceutical uses
|
|
WO2006039164A2
(en)
*
|
2004-09-29 |
2006-04-13 |
Amr Technology, Inc. |
Novel cyclosporin analogues and their pharmaceutical uses
|
|
WO2006041631A2
(en)
*
|
2004-10-06 |
2006-04-20 |
Amr Technology, Inc. |
Novel cyclosporin alkynes and their utility as pharmaceutical agents
|
|
US7135455B2
(en)
*
|
2004-11-15 |
2006-11-14 |
Allergan, Inc |
Methods for the therapeutic use of cyclosporine components
|
|
US7151085B2
(en)
*
|
2004-11-15 |
2006-12-19 |
Allergan, Inc. |
Therapeutic methods using cyclosporine components
|
|
WO2007028030A2
(en)
*
|
2005-09-02 |
2007-03-08 |
Picobella, Llc |
Oncogenic regulatory rnas for diagnostics and therapeutics
|
|
WO2007056457A2
(en)
*
|
2005-11-09 |
2007-05-18 |
Combinatorx, Incorporated |
Methods, compositions, and kits for the treatment of medical conditions
|
|
US7459280B2
(en)
*
|
2006-02-27 |
2008-12-02 |
Picobella, Llc |
Methods for diagnosing and treating kidney cancer
|
|
US7696165B2
(en)
|
2006-03-28 |
2010-04-13 |
Albany Molecular Research, Inc. |
Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders
|
|
US7696166B2
(en)
*
|
2006-03-28 |
2010-04-13 |
Albany Molecular Research, Inc. |
Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders
|
|
US20080267977A1
(en)
*
|
2007-04-26 |
2008-10-30 |
Friedrich-Alexander University Of Erlangen-Nuremberg |
Combined immunological agent and sensitizing agent for the treatment of cancer
|
|
US20100297666A1
(en)
*
|
2007-08-01 |
2010-11-25 |
Gooch Jennifer L |
Methods for determination of protein phosphatase activity, and uses in predicting therapeutic outcomes
|
|
US8394763B2
(en)
|
2007-09-26 |
2013-03-12 |
Oregon Health & Science University |
Cyclic undecapeptides and derivatives as multiple sclerosis therapies
|
|
ES2667945T3
(es)
|
2007-10-08 |
2018-05-16 |
Aurinia Pharmaceuticals Inc. |
Composiciones oftálmicas que comprenden inhibidores de calcineurina o Inhibidores de mTOR
|
|
BRPI0911709A2
(pt)
*
|
2008-07-30 |
2017-06-20 |
Isotechnika Labs Inc |
composto, processo para a produção de um composto, composição farmacêutica e método de tratar uma doença mediada a ciclofilina em um mamífero
|
|
DE102008060549A1
(de)
|
2008-12-04 |
2010-06-10 |
MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. |
Wirkstoff-Peptid-Konstrukt zur extrazellulären Anreicherung
|
|
WO2010088573A1
(en)
*
|
2009-01-30 |
2010-08-05 |
Enanta Pharmaceuticals, Inc. |
Cyclosporin analogues for preventing or treating hepatitis c infection
|
|
US8481483B2
(en)
*
|
2009-02-19 |
2013-07-09 |
Enanta Pharmaceuticals, Inc. |
Cyclosporin analogues
|
|
WO2010141584A2
(en)
*
|
2009-06-02 |
2010-12-09 |
Nikan Pharmaceuticals, Llc |
Antagonism of human formyl peptide receptor for treatment of disease
|
|
EP2440185B1
(en)
|
2009-06-09 |
2015-04-08 |
Aurinia Pharmaceuticals Inc. |
Topical drug delivery systems for ophthalmic use
|
|
US8367053B2
(en)
*
|
2009-07-09 |
2013-02-05 |
Enanta Pharmaceuticals, Inc. |
Cyclosporin analogues
|
|
US8349312B2
(en)
*
|
2009-07-09 |
2013-01-08 |
Enanta Pharmaceuticals, Inc. |
Proline substituted cyclosporin analogues
|
|
US8685917B2
(en)
*
|
2009-07-09 |
2014-04-01 |
Enanta Pharmaceuticals, Inc. |
Cyclosporin analogues
|
|
US8623814B2
(en)
*
|
2010-02-23 |
2014-01-07 |
Enanta Pharmaceuticals, Inc. |
Antiviral agents
|
|
WO2011141891A1
(en)
|
2010-05-12 |
2011-11-17 |
Debio Recherche Pharmaceutique S.A. |
Use of cycloundecadepsipeptide compounds
|
|
WO2012079172A1
(en)
|
2010-12-15 |
2012-06-21 |
Isotechnika Pharma Inc. |
Cyclosporine analogue molecules modified at amino acid 1 and 3
|
|
US9428845B1
(en)
|
2010-12-28 |
2016-08-30 |
Warp Drive Bio, Inc. |
Identifying new therapeutic agents
|
|
WO2012103520A1
(en)
|
2011-01-28 |
2012-08-02 |
Board Of Regents Of The University Of Nebraska |
Methods and compositions for modulating cyclophilin d
|
|
WO2012145426A1
(en)
|
2011-04-18 |
2012-10-26 |
The Trustees Of Columbia University In The City Of New York |
Methods to treat cancer using cyclosporine and cyclosporine derivatives
|
|
JP2015519368A
(ja)
*
|
2012-06-01 |
2015-07-09 |
アラーガン インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ |
シクロスポリンａ類似体
|
|
EP2705856A1
(en)
|
2012-09-07 |
2014-03-12 |
Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. |
Compounds for the treatment of neurodegenerative disorders
|
|
WO2014085623A1
(en)
|
2012-11-28 |
2014-06-05 |
Enanta Pharmaceuticals, Inc. |
Novel [n-me-4-hydroxyleucine]-9-cyclosporin analogues
|
|
WO2015031381A1
(en)
|
2013-08-26 |
2015-03-05 |
Enanta Pharmaceuticals, Inc. |
Cyclosporin analogues for preventing or treating hepatitis c
|
|
GB201414806D0
(en)
|
2014-08-20 |
2014-10-01 |
Ucl Business Plc |
Cyclosporin conjugates
|
|
US9669095B2
(en)
|
2014-11-03 |
2017-06-06 |
Enanta Pharmaceuticals, Inc. |
Cyclosporin analogues for preventing or treating hepatitis C infection
|
|
US9914755B2
(en)
|
2015-01-08 |
2018-03-13 |
Allergan, Inc. |
Cyclosporin derivatives wherein the MeBmt sidechain has been cyclized
|
|
US10533016B2
(en)
|
2015-01-09 |
2020-01-14 |
Revolution Medicines, Inc. |
Compounds that participate in cooperative binding and uses thereof
|
|
US10077289B2
(en)
|
2015-03-31 |
2018-09-18 |
Allergan, Inc. |
Cyclosporins modified on the MeBmt sidechain by heterocyclic rings
|
|
WO2017059207A1
(en)
*
|
2015-10-01 |
2017-04-06 |
Warp Drive Bio, Inc. |
Methods and reagents for analyzing protein-protein interfaces
|
|
JP2020501519A
(ja)
|
2016-10-28 |
2020-01-23 |
ギンゴー バイオワークス， インコーポレイテッド |
化合物の生産のための組成物および方法
|
|
US20190224275A1
(en)
|
2017-05-12 |
2019-07-25 |
Aurinia Pharmaceuticals Inc. |
Protocol for treatment of lupus nephritis
|
|
CN111449050A
(zh)
*
|
2019-01-20 |
2020-07-28 |
睿诺医疗科技（上海）有限公司 |
环孢菌素类似物及其用途
|
|
WO2021091956A1
(en)
|
2019-11-04 |
2021-05-14 |
Revolution Medicines, Inc. |
Ras inhibitors
|
|
CN120699039A
(zh)
|
2019-11-04 |
2025-09-26 |
锐新医药公司 |
Ras抑制剂
|
|
MX2022005359A
(es)
|
2019-11-04 |
2022-06-02 |
Revolution Medicines Inc |
Inhibidores de ras.
|
|
IL296586B1
(en)
|
2020-03-26 |
2026-04-01 |
Farsight Medical Tech Shanghai Co Ltd |
Cyclophilin inhibitors and their uses
|
|
CA3172689A1
(en)
*
|
2020-03-26 |
2021-09-30 |
Ching-Pong Mak |
Cyclophilin inhibitors and uses thereof
|
|
MX2023003060A
(es)
|
2020-09-15 |
2023-04-05 |
Revolution Medicines Inc |
Derivados indolicos como inhibidores de ras en el tratamiento del cancer.
|
|
AU2022268962A1
(en)
|
2021-05-05 |
2023-12-14 |
Revolution Medicines, Inc. |
Ras inhibitors for the treatment of cancer
|
|
AR127308A1
(es)
|
2021-10-08 |
2024-01-10 |
Revolution Medicines Inc |
Inhibidores ras
|